High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 1900-1908

  Eggert, Angelika ^a   Ikegaki, Naohiko ^a   Kwiatkowski, Janet ^a   Zhao, Huaqing ^a   Brodeur, Garrett M ^a   Himelstein, Bruce P ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ADVANCED CANCER; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; INFANT; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; NEOPLASM STAGING; NEUROBLASTOMA; PLATELET-DERIVED GROWTH FACTOR; PROTEINS; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034031079     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Folkman, J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res., 46: 467-473, 1986.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1989.
3. Folkman, J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
4. Bar, R. S., Boes, M., Booth, B. A., Duke, B. L., Henley, S., and Hart, M. N. The effects of PDGF in cultured microvessel endothelial cells. Endocrinology, 124: 1841-1848, 1989.
5. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
6. Hanahan, D. Signaling vascular morphogenesis and maintenance. Science (Washington DC), 277: 48-50, 1997.
7. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. Angiopoietin-2, a natural antagonist for tie-2, that disrupts in vivo angiogenesis. Science (Washington DC), 277: 55-60, 1997.
8. Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbahn, A., Funa, K., and Heldin, C. H. Platelet-derived growth factor is angiogenic in vivo. Growth Factors, 7: 261-266, 1992.
9. New, B. A., and Yeoman, L. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J. Cell. Physiol., 150: 320-326, 1992.
10. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., and Yancopoulos, G. D. Requisite role of angiopoietin-1, a ligand for the tie-2 receptor, during embryonic angiogenesis. Cell, 87: 1171-1180, 1996.
11. Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J-H., Claesson-Welsh, L., and Alitalo, K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA, 95: 14389-14394, 1998.
12. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
13. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
14. Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res., 56: 2013-2016, 1996.
15. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
16. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95: 1789-1797, 1995.
17. de Vries, C., Escobido, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
18. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Boehlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1992.
19. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
20. Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T., and Levi, B. Z. Vascular endothelial growth factor and its receptors. Prog. Growth Factor Res., 5: 89-97, 1994.
21. Houck, K. A., Leung, D. W., Rowland, A. M., Wlner, J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267: 26031-26037, 1992.
22. Asano, M., Yukita, A., Matsumoto, T., Kondo, S., and Suzuki, H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Cancer Res., 55: 5296-5301, 1995.
23. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Philipps, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
24. Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V., Saksela, O., Orpana, A., Pettersson, R. E., Alitalo, K., and Eriksson, U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. Res. USA, 93: 2576-2581, 1996.
25. Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K., and Eriksson, U. Genomic organisation of the mouse and human genes for vascular endothelial growth f factor B (VEGF B) and characterization of a second splice isoform. J. Biol. Chem., 271: 19310-19317, 1996.
26. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15: 290-298, 1996.
27. Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., and Alitalo, K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA, 92: 3566-3570, 1995.
28. Salven, P., Lymboussaki, A., Heikkila, P., Jaaskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K., and Joensuu, H. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am. J. Pathol., 153: 103-108, 1998.
29. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., bruno, J., Radziejewski, C., Maisonpierre, P. C., and Yancopoulos, G. D. Isolation of angiopoietin-1, a ligand for the tie-2 receptor, by secretion-trap expression cloning. Cell, 87: 1161-1169, 1996.
30. Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J. A., Fiddes, J. C., and Gospodarowicz, D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (Lond.), 325: 257-259, 1987.
31. Schweigerer, L., Neufeld, G., and Gospodarowicz, D. Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J. Clin. Invest., 80: 1516-1520, 1987.
32. Schweigerer, L., Neufeld, G., Mergia, A., Abraham, J. A., Fiddes. J. C., and Gospodarowicz, D. Basic fibroblast growth factor in cultured embryonal rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc. Natl. Acad. Sci. USA, 84: 842-846, 1987.
33. Smith, K., Fox, S. B., Whitehouse, R., Taylor, M., Greenall, M., Clarke, J., and Harris, A. L. Up-regulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann. Oncol., 10: 707-713, 1999.
34. Heldin, C-H. Structural and functional studies on platelet-derived growth factor. EMBO J., 11: 4251-4259, 1992.
35. Ross, R., Raines, E. W., and Bowen-Pope, D. F. The biology of platelet-derived growth factor. Cell, 46: 155-169, 1986.
36. Gille, J., Swerlick, R. A., and Caughman, S. W. Transforming growth factor-α-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J., 18: 50-59, 1997.
37. Rappolee, D. A., Mark, D., Banda, M. J., and Werb, Z. Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science (Washington DC), 241: 708-712, 1991.
38. Ciardiello, F., Kim, N., McGeady, M. L., Liscia, D. S., Saeki, T., Bianco, C., and Salomon, D. Expression of transforming growth factor a (TGFα) in breast cancer. Ann. Oncol., 2: 169-82, 1991.
39. Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., and White, P. S. Biology and genetics of human neuroblastomas. J. Pediatr. Hematol. Oncol., 19: 93-101, 1997.
40. Meitar, D., Crawford, S. E., Rademaker, A. W., and Cohn, S. L. Tumor angiogenesis correlates with metastatic disease. N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol., 14: 405-414, 1996.
41. Roessler, J., Breit, S., Havers, W., and Schweigerer, L. Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia. Int. J. Cancer, 81: 113-117, 1999.
42. Meister, B., Grunebach, F., Bautz, F., Brugger, W., Fink, F. M., Kanz, L., and Mohle, R. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur. J. Cancer, 35: 445-449, 1999.
43. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 156-159, 1987.
44. Anan, K., Morisaki, T., Katano, M., Ikubo, A., Kitsuki, H., Uchiyama, A., Kuroki, S., Tanaka, M., and Torisu, M. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery, 119: 333-339, 1996.
45. Schmidt, M. L., Salwen, H. R., Manohar, C. F., Ikegaki, N., and Cohn, S. L. The biologic effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ., 5: 171-178, 1994.
46. Shimada, H., Chatten, J., Newton, W. A. J., Sachs, N., Hamoudi, A. B., Chiba, T., Marsden, H. B., and Misugi, K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl. Cancer Inst., 73: 405-416, 1984.
47. Brodeur, G. M., Seeger, R. C., Barrett, A., Berthold, F., Castleberry, R. P., D'Angio, G., De Bernardi, B., Evans, A. E., Favrot, M., and Freeman, A. I. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol., 6: 1874-1881, 1988.
48. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., and Brodeur, G. M. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastomas. N. Engl. J. Med., 328: 847-854, 1993.
49. Suzuki, T., Bogenmann, E., Shimada, H., Starm, D., and Seeger, R. Lack of high affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl. Cancer Inst., 85: 377-384, 1993.
50. Kogner, P., Barbany, G., Dominici, C., Castello, M., Raschella, G., and Persson, H. Coexpression of messenger RNA for Trk proto-oncogene and low affinity nerve growth factor receptor in neuroblastomas with favorable prognosis. Cancer Res., 53: 2044-2050, 1993.
51. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
52. Bosari, S., Lee, A. K. C., Dlellis, R. A., Wiley, B. D., Heatley, G. J., and Silverman, M. L. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol., 23: 755-761, 1992.
53. Guidi, A. J., Fischer, L., Harris, J. R., and Schnitt, S. J. Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst., 86: 614-619, 1994.
54. Schweigerer, L., Breit, S., Wenzel, A., Tsunamoto, K., Ludwig, R., and Schwab, M. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells. Evidence for induction of autocrine growth activity. Cancer Res., 50: 4411-4416, 1990.
55. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 189: 824-831, 1992.
56. Wassberg, E., Pahlman, S., Westlin, J. E., and Christofferson, R. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr. Res., 41: 327-333, 1997.